Page last updated: 2024-10-30

meclizine and Huntington Disease

meclizine has been researched along with Huntington Disease in 1 studies

Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.

Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gohil, VM1
Offner, N1
Walker, JA1
Sheth, SA1
Fossale, E1
Gusella, JF1
MacDonald, ME1
Neri, C1
Mootha, VK1

Other Studies

1 other study available for meclizine and Huntington Disease

ArticleYear
Meclizine is neuroprotective in models of Huntington's disease.
    Human molecular genetics, 2011, Jan-15, Volume: 20, Issue:2

    Topics: Animals; Apoptosis; Caenorhabditis elegans; Cell Respiration; Disease Models, Animal; Drosophila mel

2011